Whole-Body FDG PET Imaging in Oncology, 1st Edition

  • Published By:
  • ISBN-10: 8847052955
  • ISBN-13: 9788847052956
  • DDC: 616.99
  • Grade Level Range: College Freshman - College Senior
  • 352 Pages | eBook
  • Original Copyright 2014 | Published/Released May 2014
  • This publication's content originally published in print form: 2014

  • Price:  Sign in for price



This manual presents a large collection of clinical cases in oncology with accompanying whole-body FDG PET-CT scans. The aim is to promote an integrated approach to the use of PET-CT, and detailed attention is therefore paid to the clinical history and diagnostic question.  A central aspect of every clinical case described in this manual is the guidance on the clinical report, which is the official tool for communicating with both the referring physician and the person undergoing the diagnostic test; for this reason it needs to be clear, understandable, and written in shared language. The advice regarding report preparation is strongly supported by informative PET, CT, and PET-CT fused images of each disease. The book is broadly structured according to anatomic region, and a wide range of common diseases likely to be imaged using PET-CT is covered. This book will be of value to all those training or working in the field of oncology who wish to ensure that they are best placed to contextualize, interpret, and report the findings obtained with PET-CT, which can have such a dramatic impact on prognosis, therapeutic choice, and quality of life.​

Table of Contents

Front Cover.
Half Title Page.
Title Page.
Copyright Page.
Other Frontmatter.
1: Cholecystis and Biliary Ducts.
2: Recurrent Gallbladder Carcinoma.
3: Recurrent Klatskin's Tumor: Peritoneal Carcinosis.
4: Head-Neck.
5: Parotid Cancer Recurrence and Metachronous Lung Cancer.
6: Laryngeal Squamous Carcinoma: Staging.
7: Squamous Neoplasia of the Subglottic Region.
8: Squamous Ulcerated Carcinoma of the Tongue: Restaging after Chemotherapy.
9: Undifferentiated Carcinoma of the Nasopharynx: Restaging after Surgery and Radiochemotherapy.
10: Zygomatic Spinalioma and Synchronous Pulmonary Neoplasm.
11: Bone-Destroying Metastases in Thyroid Undifferentiated Carcinoma.
12: Post-Actinic Mandibular Fracture in a Patient with a Radio-Treated Nasopharyngeal Cancer in Remission.
13: Nodal Metastases in Nasal Squamous Carcinoma.
14: Jugular Ulcerated Cutaneous Spinalioma.
15: Colon-Rectum.
16: Hepatic Metastases in Rectal Cancer.
17: Radio-Treated Cancer of the Posterior Hemi-Circumference of the Anal Canal: Post-Actinic Fibrosis.
18: Liver Metastases in Mucinous Adenocarcinoma of the Colon: Low Metabolism of FDG.
19: Hepatic Metastases from Carcinoma of the Transverse Colon: Persistent Disease after Thermal Ablation.
20: Surgically Treated Adenocarcinoma of the Rectum: Locoregional Recurrence with Lymph Node Metastases.
21: Rectal Adenocarcinoma and Hepatic Metastases: Partial Response to Chemotherapy.
22: Sigmoid Adenocarcinoma: Post-Actinic Tardive Sacral Fracture.
23: Locoregional Recurrence of Mucinous Adenocarcinoma of the Transverse Colon.
24: Esophagus.
25: Esophageal Cancer in Patient with Ulcerative Colitis.
26: Esophageal Cancer and Secondary Nodal Metastases.
27: Gynecology.
28: Locoregional Recurrence of Carcinoma of the Uterus with Lymph Node Metastasis that Determines Lymphedema and Obstructive Hydronephrosis.
29: Ovarian Cancer and Peritoneal Carcinosis: Follow-up after Chemotherapy.
30: Ovarian Cancer: Diagnosis and Progression of Disease.
31: Staging of Metastatic Sarcoma of the Uterus.
32: Cervical Cancer: Staging.
33: Peritoneal Cancer Recurrence.
34: Vaginal Adenocarcinoma: Restaging after Chemoradiotherapy.
35: Recurrence of Left Ovarian Adult-Type Granulosa Cell Tumor.
36: Surgically Treated Endometrial Cancer: Bilateral Nodal Recurrence.
37: Follow-up of Carcinoma of the Uterus: Left Lower Limb Lymphedema Due to Fibrous Scar.
38: Squamous Cell Vulvar Surgically Treated Carcinoma: Nodal Recurrence of Disease.
39: Post-actinic Fracture of the Pubic Symphysis in Woman with a History of Cancer of the Uterus and Vulva.
40: Lymphomas and Thymomas.
41: Non-Hodgkin Lymphoma: Diagnosis.
42: Follow-up of T-lymphoblastic Lymphoma During Chemotherapy, in Patient Who Underwent Radiotherapy and Talc Pleurodesis.
43: NHL: Evaluation of the Response to Chemotherapy.
44: Mediastinal Mass: Thymic Carcinoma.
45: Hodgkin's Lymphoma: Response to Chemotherapy.
46: Granulomatosis.
47: Microscopically and Macroscopically Capsulated Stage IA Thymoma.
48: Ocular Lymphoma.
49: Breast.
50: DIC of the Left Breast with Liver Metastases: Metabolic Response to Chemotherapy.
51: Breast Carcinoma: Single Pulmonary and Multiple Lymph-nodal Metastases.
52: Infiltrating Ductal Carcinoma with Solitary Liver Metastasis.
53: Metastatic Breast Carcinoma: Restaging after Neoadjuvant Chemotherapy.
54: Staging of Breast Cancer with Axillary Lymphadenopathy.
55: Man with Breast Cancer Follow-up after Surgery: Scar Glucose Uptake.
56: Breast Cancer: Post-Surgical Brachial Plexopathy.
57: Follow-up of Papillary Breast Cancer: Solitary Sacroiliac Benign Lesion.
58: Breast Cancer Follow-up: Nodal and Skeletal Progression of Disease.
59: Bone Metastases from Breast Cancer: Progression of Disease and Subsequent Response to Radiotherapy.
60: Axillary Lymphadenopathy of Nature to be Determined.
61: Brachial Plexopathy Secondary to Axillary Recurrence of Breast Cancer: Response to Chemoradiotherapy.
62: Melanoma.
63: Malignant Melanoma.
64: Axillary Metastases in Patient with Melanoma: Post-Surgery Evaluation.
65: Pancreas.
66: Ductal and Mucinous Pancreatic Adenocarcinoma: Recurrence after Surgery.
67: Pancreatic Adenocarcinoma: Diagnosis.
68: Diffuse Peritoneal Carcinosis Due to Pancreatic Adenocarcinoma.
69: Lung.
70: Pulmonary Nodule in Patient with Severe Interstitial Fibrosis.
71: After Surgery Follow-up in Patient with NSCLC: Muscular Metastases.
72: Anaplastic Metastatic Pulmonary Cancer: Follow-up After Radiotherapy.
73: Lymphocytic Interstitial Pneumonia in Patient with History of Breast Cancer.
74: Mucinous Cancer Recurrence.
75: Epidermoid Pulmonary Cancer: Follow-up after Surgery.
76: Pulmonary Cancer with Numerous Nodal Hilar-Mediastinic and Bone Metastases.
77: Follow-up of Pulmonary Cancer after Surgery: Granulomatous Reaction on Scar.
78: Left Pulmonary Cancer: Follow-up after Pneumonectomy.
79: Pulmonary Solitary Nodule in Patient with Prostatic Adenocarcinoma in Follow-up.
80: Bronchial Chemotreated Carcinoid: Progression of Disease.
81: Pulmonary Actinomycosis in Dialysis Patient.
82: Pulmonary Adenocarcinoma with Pleural Metastases: Restaging after Radiotherapy and Pleural Talcage.
83: NSCLC with Bone-Destroying Metastases: Restaging after Chemotherapy.
84: Stomach.
85: Undifferentiated Gastric Adenocarcinoma with Peritoneal Carcinosis.
86: Infiltrating Gastric Adenocarcinoma: Follow-up after Neoadjuvant Chemotherapy.
87: Metastatic Gastric Adenocarcinoma: Progression of Disease.
88: Urinary Tract.
89: Follow-up of Bladder Carcinoma: Incidental Diagnosis of Metachronous Pulmonary Cancer.
90: Urothelial Carcinoma of the Bladder and Prostatic Adenocarcinoma: Progression of Disease after Surgery.
91: High-Grade Urothelial Carcinoma: Progression of Disease after Surgery.
92: Urothelial Carcinoma: Follow-up after Surgery.